[H]C12CC([H])(C3([H])OC13[H])C1([H])C3(Cl)C(Cl)=C(Cl)C(Cl)(C3(Cl)Cl)C21[H]
Assay: DRUGMATRIX inhibits MAO-A using Kynuramine as substrate with a single protein target (Homologous). The assay is In vitro, with Binding as the type description and BTI-TN-5B1-4 as the cell type. Does the molecule work for this assay?